Candida parapsilosis is the second most frequent Candida species isolated from blood cultures. Since 2005, C. parapsilosis has been divided into three distinct species based on genetic traits: Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis. The aim of this study was to develop a rapid real-time PCR assay able to distinguish these closely related species via a melting curve analysis. This identification method was optimized by using reference strains and well-characterized clinical isolates of Candida species. A single set of consensus primers was designed to amplify a 184 bp portion of the SADH gene in order to identify species based on the unique melt profile resulting from DNA sequence variations from each species of the complex. PCR products were detected with SYBR Green fluorescent dye and identification was established by melting curve analysis. For validation of the technique, a total of 116 clinical isolates, phenotypically identified as C. parapsilosis, were tested by real-time PCR and results were further compared with PCR-RFLP patterns of the SADH gene, used as the reference method. The melting curve analysis of amplified DNA could differentiate between C. parapsilosis (83.5 6C), C. metapsilosis (82.9 6C) and C. orthopsilosis (82.1 6C), with a sensitivity and specificity comparable to those of the reference method. One hundred and fourteen C. parapsilosis and two C. orthopsilosis isolates were identified among the clinical isolates. This method provides a simple, rapid and reliable identification of species belonging to the C. parapsilosis complex. This novel approach could be helpful for clinical and epidemiological investigations.
INTRODUCTION
Among Candida species, Candida parapsilosis is the second most frequently isolated from bloodstream infections in many regions of the world, especially in Latin America and Asia, while it is also common in Europe (Almirante et al., 2006) . C. parapsilosis emerged in the 1990s and its incidence is still increasing (Playford et al., 2010) . This is partly due to the massive usage of medical devices, notably among immunocompromised patients, and to the selective pressure exerted by the intensive use of azoles and more recently of echinocandins (Bassetti et al., 2009; Forrest et al., 2008; Trofa et al., 2008) . C. parapsilosis is also known to be a nosocomial yeast responsible for bloodstream infections, mainly in intensive care units, transmitted by the hands of healthcare workers (van Asbeck et al., 2007) . Moreover, its ability to form biofilms on medical implants, like Candida albicans, confers increased resistance to antifungal agents, leading to a real therapeutic problem (Kuhn et al., 2002; Rů žička et al., 2007) .
Since 2005, C. parapsilosis has been considered to be a species complex, including three distinct species based on genetic criteria: C. parapsilosis, Candida metapsilosis and Candida orthopsilosis (Tavanti et al., 2005) . Epidemiological and clinical features corresponding to each species have been poorly documented since their phenotypic identification remains unreliable. Therefore, the rapid identification of Candida species in clinical laboratories appears essential for the management of patients with candidaemia.
The aim of this study was to develop a rapid real-time PCR assay able to distinguish these three closely related species via a melting curve analysis. After optimization of this technique, we tested 116 clinical isolates, previously identified by conventional methods as C. parapsilosis, and compared with PCR-RFLP patterns of the SADH gene, used as the reference method.
ATCC 22019, C. metapsilosis CBS 10907 and C. orthopsilosis CBS 10906 were included in the study as reference strains. Three clinical strains, identified as C. orthopsilosis by sequencing, were also studied (gift from M.-E. Bougnoux, Hôpital Necker-Enfants Malades, Paris, France). Other Candida species of clinical interest were used to ensure the technique specificity: C. albicans, Candida glabrata, Candida tropicalis, Candida krusei, Candida kefyr, Candida lusitaniae, Candida dubliniensis, Candida famata, Candida colliculosa and Candida sphaerica. A clinical isolate identified as Saccharomyces cerevisiae and the Lodderomyces elongiporus reference strain CBS 2605 were also tested. Each strain was cultured in YPD liquid medium (2 % glucose, 2 % peptone, 1 % yeast extract) overnight at 30 uC with agitation and stored at -80 uC.
DNA extraction. Yeast genomic DNA was extracted with the MasterPure Yeast DNA Purification kit (Epicentre Biotechnologies) according to the manufacturer's instructions.
Real-time PCR and melting curve analysis. After aligning the SADH sequences of the three species, a single set of consensus primers was carefully designed to amplify a 184 bp portion of the gene, in order to identify species based on the unique melt profile resulting from DNA sequence variations from each C. parapsilosis complex species. The 25 ml reaction mixture consisted of 12.5 ml SYBR Green PCR Master Mix 26 (Qiagen), 2.5 ml forward and reverse primers (10 mmol l 21 ) (SADH-F 59-GCTGCGGCTTCAACTGATGC-39 and SADH-R 59-CTTGGTCACGAGCCTCC-39), 5.5 ml distilled water and 2.0 ml DNA sample (approx. 150 ng). Real-time PCR and melting curve analysis were carried out using a Rotor-Gene Q thermocycler (Qiagen). The experimental conditions used were as follows: 5 min at 95 uC, followed by 40 cycles of 10 s at 95 uC, 30 s at 64 uC and 20 s at 72 uC. Melting curves were generated after the last extension step; the temperature was ramped from 55 uC to 95 uC, 0.5 uC every 5 s. Melting curves were analysed by the Rotor-Gene 1.7 software (Qiagen).
PCR-RFLP analysis. Results for each strain identified by real-time PCR and melting curve analysis were compared to those obtained with PCR-RFLP used as the reference method, as previously described (Asadzadeh et al., 2009) . Briefly, primers SADHF2 (59-TGGATTG-TGGGGAYAATTATGT-39) and SADHR2 (59-GTCAATACRGCAT-CAGTTGAAGC-39) were used to amplify a 310 bp fragment of the SADH gene. Subsequently, PCR products were digested with the restriction enzyme BanI.
Statistical analysis. Student's t test was used to establish differences between test groups. A P-value of ,0.05 was considered significant.
RESULTS AND DISCUSSION
The primers SADH-F and SADH-R were designed to amplify a portion of the SADH gene, with a DNA G+C content difference between the three species (C. parapsilosis, 45.1 mol%; C. metapsilosis, 43.5 mol%; and C. orthopsilosis, 41.3 mol%). This difference allowed species identification with three significantly different melting temperatures: 83.5± 0.19 u C, 82.9±0.15 u C and 82.1±0.25 u C for C. parapsilosis, C. metapsilosis and C. orthopsilosis, respectively (P,0.05) (Fig. 1) . A difference of 0.7 u C maximum in the melting peak temperatures could be observed between different runs, but not within the same run. This disparity probably resulted from variations in the temperature profile created by the thermocycler, requiring the use of reference strains DNA in each set as positive controls. No amplification was observed with C. albicans, C. glabrata, C. tropicalis, C. krusei, C. kefyr, C. lusitaniae, C. dubliniensis, C. famata, C. colliculosa, C. sphaerica, S. cerevisiae or L. elongiporus (specificity, 100 %). The latter species is very close phenotypically and genetically to C. parapsilosis, formerly considered as its teleomorph, resulting in misidentification by conventional methods (Lockhart et al., 2008a) . Concerning the PCR-RFLP reference method, the BanI-digested PCR products generated two fragments of 166 and 144 bp, two fragments of 268 and 42 bp, and one undigested fragment of 310 bp for C. parapsilosis, C. metapsilosis and C. orthopsilosis, respectively, as expected.
Since C. parapsilosis was considered a species complex and divided into three species, several identification methods have been developed, based on PCR-RFLP (Tavanti et al., 2005; Asadzadeh et al., 2009 ) and internal transcribed spacer sequencing (Gomez-Lopez et al., 2008; Borman et al., 2009 ). An amplification fragment length polymorphism method has also been used not only to confirm species identification, but also to evaluate genetic relatedness of C. parapsilosis (Tavanti et al., 2010) , C. metapsilosis (Hensgens et al., 2009) and C. orthopsilosis (Tavanti et al., 2007) analysis was developed to identify six Candida species of clinical interest, including C. parapsilosis complex species . However, this technique has not yet been optimized to enable species-level identification of the C. parapsilosis complex. In our study, the melting curve analysis of amplified DNA could differentiate between the three species of the C. parapsilosis complex with a sensitivity and specificity comparable to those of the PCR-RFLP reference method.
The 116 clinical isolates, previously identified by conventional methods as C. parapsilosis, were correctly amplified and detected with SYBR Green fluorescent dye, as were the three C. orthopsilosis clinical strains. Based on the melting curve analysis, 114 (98.3 %) and two (1.7 %) were identified as C. parapsilosis and C. orthopsilosis, respectively, with 100 % correlation with the PCR-RFLP reference method. The three C. orthopsilosis clinical strains were correctly identified with the two methods. No C. metapsilosis was identified among these clinical isolates. Although epidemiological data are still rare, this species distribution seemed unusual. Indeed, among C. parapsilosis complex species, the percentage of C. orthopsilosis and C. metapsilosis was low compared to that in Asia (11 % of C. orthopsilosis and 2.6 % of C. metapsilosis), Europe and the Middle East (3.5 % of C. orthopsilosis and 2.9 % of C. metapsilosis), South America (10.9 % of C. orthopsilosis and 1.3 % of C. metapsilosis) and North America (5 % of C. orthopsilosis and 0.6 % of C. metapsilosis) (Lockhart et al., 2008b) . Europe is generally considered to be the region with the higher rate of C. metapsilosis (Lockhart et al., 2008b) .
In this study, 56 % of the C. parapsilosis isolates were from patients over 60 years of age, with a median age of 55 years. C. parapsilosis is usually described as an important pathogen in children and neonates. We found that 8.9 % of the C. parapsilosis isolates were from children under 1 year, consistent with the majority of publications (Filioti et al., 2007) .
This method provides a simple, rapid (less than 3 h, including DNA extraction) and reliable identification of species belonging to the C. parapsilosis complex. In addition, it seems to be cost-effective since no specific probes are needed in this assay. This novel approach may be helpful for clinical and epidemiological investigations. To our knowledge, we have developed the first rapid and accurate real-time PCR for species differentiation within the C. parapsilosis complex. 
